0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Gene Therapy Biomanufacturing Market Research Report 2026
Published Date: 2026-03-30
|
Report Code: QYRE-Auto-33E17215
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Gene Therapy Biomanufacturing Market Research Report 2024
BUY CHAPTERS

Global Cell Gene Therapy Biomanufacturing Market Research Report 2026

Code: QYRE-Auto-33E17215
Report
2026-03-30
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell Gene Therapy Biomanufacturing Market Size

The global Cell Gene Therapy Biomanufacturing market was valued at US$ 16880 million in 2025 and is anticipated to reach US$ 33870 million by 2032, at a CAGR of 10.6% from 2026 to 2032.

Cell Gene Therapy Biomanufacturing Market

Cell Gene Therapy Biomanufacturing Market

Cell and gene therapy (CGT) includes the injection of cells, genes, or gene-modified cells into a patient with the purpose of preventing or treating a disease. Cell therapy involves the injection of cells to replace or aid the repair of damaged cells, whereas gene therapy involves the injection of genes into cells to alter the genetic makeup of the recipient cells. Cell-based gene therapies, such as chimeric antigen receptor T (CAR-T) therapy, represent combinations of both approaches.
In recent years, the demand for cell and gene therapy (CGT) has surged as the number of United States Food and Drug Administration (U.S. FDA)-approved CGT products has increased annually. This increasing demand underscores the pressing need for manufacturers to improve and advance their production processes to keep pace with the rapidly evolving CGT field. The entire CGT manufacturing process must occur in a facility that complies with good manufacturing practice (GMP) regulations and has received full authorization to manufacture CGTs or advanced-therapy medicinal products, as they are referred to in Europe, for human use. Numerous clinical trials have been conducted to assess the safety and efficacy of CGTs for a wide range of clinical indications, including cancer.
This report delivers a comprehensive overview of the global Cell Gene Therapy Biomanufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Gene Therapy Biomanufacturing. The Cell Gene Therapy Biomanufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell Gene Therapy Biomanufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell Gene Therapy Biomanufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cell Gene Therapy Biomanufacturing Market Report

Report Metric Details
Report Name Cell Gene Therapy Biomanufacturing Market
Accounted market size in 2025 US$ 16880 million
Forecasted market size in 2032 US$ 33870 million
CAGR 10.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Consumables
  • Equipment
  • Software Solutions
Segment by Application
  • Life Science Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Cell Banks
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza Group, Thermo Fisher Scientific Inc., Merck KGaA, WuXi AppTec, Catalent, Inc., Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Charles River Laboratories, Cytiva, Novasep
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Cell Gene Therapy Biomanufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Cell Gene Therapy Biomanufacturing Market growing?

Ans: The Cell Gene Therapy Biomanufacturing Market witnessing a CAGR of 10.6% during the forecast period 2026-2032.

What is the Cell Gene Therapy Biomanufacturing Market size in 2032?

Ans: The Cell Gene Therapy Biomanufacturing Market size in 2032 will be US$ 33870 million.

Who are the main players in the Cell Gene Therapy Biomanufacturing Market report?

Ans: The main players in the Cell Gene Therapy Biomanufacturing Market are Lonza Group, Thermo Fisher Scientific Inc., Merck KGaA, WuXi AppTec, Catalent, Inc., Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Charles River Laboratories, Cytiva, Novasep

What are the Application segmentation covered in the Cell Gene Therapy Biomanufacturing Market report?

Ans: The Applications covered in the Cell Gene Therapy Biomanufacturing Market report are Life Science Companies, Contract Research Organizations, Contract Manufacturing Organizations, Cell Banks

What are the Type segmentation covered in the Cell Gene Therapy Biomanufacturing Market report?

Ans: The Types covered in the Cell Gene Therapy Biomanufacturing Market report are Consumables, Equipment, Software Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Consumables
1.2.3 Equipment
1.2.4 Software Solutions
1.3 Market by Application
1.3.1 Global Cell Gene Therapy Biomanufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Life Science Companies
1.3.3 Contract Research Organizations
1.3.4 Contract Manufacturing Organizations
1.3.5 Cell Banks
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Gene Therapy Biomanufacturing Market Perspective (2021–2032)
2.2 Global Cell Gene Therapy Biomanufacturing Growth Trends by Region
2.2.1 Global Cell Gene Therapy Biomanufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell Gene Therapy Biomanufacturing Historic Market Size by Region (2021–2026)
2.2.3 Cell Gene Therapy Biomanufacturing Forecasted Market Size by Region (2027–2032)
2.3 Cell Gene Therapy Biomanufacturing Market Dynamics
2.3.1 Cell Gene Therapy Biomanufacturing Industry Trends
2.3.2 Cell Gene Therapy Biomanufacturing Market Drivers
2.3.3 Cell Gene Therapy Biomanufacturing Market Challenges
2.3.4 Cell Gene Therapy Biomanufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Gene Therapy Biomanufacturing Players by Revenue
3.1.1 Global Top Cell Gene Therapy Biomanufacturing Players by Revenue (2021–2026)
3.1.2 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell Gene Therapy Biomanufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell Gene Therapy Biomanufacturing Revenue
3.4 Global Cell Gene Therapy Biomanufacturing Market Concentration Ratio
3.4.1 Global Cell Gene Therapy Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Gene Therapy Biomanufacturing Revenue in 2025
3.5 Global Key Players of Cell Gene Therapy Biomanufacturing Head Offices and Areas Served
3.6 Global Key Players of Cell Gene Therapy Biomanufacturing, Products and Applications
3.7 Global Key Players of Cell Gene Therapy Biomanufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell Gene Therapy Biomanufacturing Breakdown Data by Type
4.1 Global Cell Gene Therapy Biomanufacturing Historic Market Size by Type (2021–2026)
4.2 Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Type (2027–2032)
5 Cell Gene Therapy Biomanufacturing Breakdown Data by Application
5.1 Global Cell Gene Therapy Biomanufacturing Historic Market Size by Application (2021–2026)
5.2 Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
6.2 North America Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
6.4 North America Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
7.2 Europe Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
7.4 Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
8.2 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
9.2 Latin America Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
9.4 Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size (2021–2032)
10.2 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Cell Gene Therapy Biomanufacturing Introduction
11.1.4 Lonza Group Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.1.5 Lonza Group Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Cell Gene Therapy Biomanufacturing Introduction
11.3.4 Merck KGaA Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.3.5 Merck KGaA Recent Development
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Details
11.4.2 WuXi AppTec Business Overview
11.4.3 WuXi AppTec Cell Gene Therapy Biomanufacturing Introduction
11.4.4 WuXi AppTec Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.4.5 WuXi AppTec Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Details
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Cell Gene Therapy Biomanufacturing Introduction
11.5.4 Catalent, Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.5.5 Catalent, Inc. Recent Development
11.6 Samsung Biologics
11.6.1 Samsung Biologics Company Details
11.6.2 Samsung Biologics Business Overview
11.6.3 Samsung Biologics Cell Gene Therapy Biomanufacturing Introduction
11.6.4 Samsung Biologics Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.6.5 Samsung Biologics Recent Development
11.7 FUJIFILM Diosynth Biotechnologies
11.7.1 FUJIFILM Diosynth Biotechnologies Company Details
11.7.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.7.3 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Introduction
11.7.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.7.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Cell Gene Therapy Biomanufacturing Introduction
11.8.4 Charles River Laboratories Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.8.5 Charles River Laboratories Recent Development
11.9 Cytiva
11.9.1 Cytiva Company Details
11.9.2 Cytiva Business Overview
11.9.3 Cytiva Cell Gene Therapy Biomanufacturing Introduction
11.9.4 Cytiva Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.9.5 Cytiva Recent Development
11.10 Novasep
11.10.1 Novasep Company Details
11.10.2 Novasep Business Overview
11.10.3 Novasep Cell Gene Therapy Biomanufacturing Introduction
11.10.4 Novasep Revenue in Cell Gene Therapy Biomanufacturing Business (2021–2026)
11.10.5 Novasep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Consumables
 Table 3. Key Players of Equipment
 Table 4. Key Players of Software Solutions
 Table 5. Global Cell Gene Therapy Biomanufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Cell Gene Therapy Biomanufacturing Market Share by Region (2021–2026)
 Table 9. Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Cell Gene Therapy Biomanufacturing Market Share by Region (2027–2032)
 Table 11. Cell Gene Therapy Biomanufacturing Market Trends
 Table 12. Cell Gene Therapy Biomanufacturing Market Drivers
 Table 13. Cell Gene Therapy Biomanufacturing Market Challenges
 Table 14. Cell Gene Therapy Biomanufacturing Market Restraints
 Table 15. Global Cell Gene Therapy Biomanufacturing Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Cell Gene Therapy Biomanufacturing Market Share by Players (2021–2026)
 Table 17. Global Top Cell Gene Therapy Biomanufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell Gene Therapy Biomanufacturing Revenue, 2025
 Table 18. Ranking of Global Top Cell Gene Therapy Biomanufacturing Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Cell Gene Therapy Biomanufacturing Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Cell Gene Therapy Biomanufacturing, Headquarters and Area Served
 Table 21. Global Key Players of Cell Gene Therapy Biomanufacturing, Products and Applications
 Table 22. Global Key Players of Cell Gene Therapy Biomanufacturing, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Cell Gene Therapy Biomanufacturing Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Type (2021–2026)
 Table 26. Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Type (2027–2032)
 Table 28. Global Cell Gene Therapy Biomanufacturing Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Application (2021–2026)
 Table 30. Global Cell Gene Therapy Biomanufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Application (2027–2032)
 Table 32. North America Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Country (US$ Million), 2027–2032
 Table 47. Lonza Group Company Details
 Table 48. Lonza Group Business Overview
 Table 49. Lonza Group Cell Gene Therapy Biomanufacturing Product
 Table 50. Lonza Group Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 51. Lonza Group Recent Development
 Table 52. Thermo Fisher Scientific Inc. Company Details
 Table 53. Thermo Fisher Scientific Inc. Business Overview
 Table 54. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product
 Table 55. Thermo Fisher Scientific Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 56. Thermo Fisher Scientific Inc. Recent Development
 Table 57. Merck KGaA Company Details
 Table 58. Merck KGaA Business Overview
 Table 59. Merck KGaA Cell Gene Therapy Biomanufacturing Product
 Table 60. Merck KGaA Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 61. Merck KGaA Recent Development
 Table 62. WuXi AppTec Company Details
 Table 63. WuXi AppTec Business Overview
 Table 64. WuXi AppTec Cell Gene Therapy Biomanufacturing Product
 Table 65. WuXi AppTec Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 66. WuXi AppTec Recent Development
 Table 67. Catalent, Inc. Company Details
 Table 68. Catalent, Inc. Business Overview
 Table 69. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product
 Table 70. Catalent, Inc. Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 71. Catalent, Inc. Recent Development
 Table 72. Samsung Biologics Company Details
 Table 73. Samsung Biologics Business Overview
 Table 74. Samsung Biologics Cell Gene Therapy Biomanufacturing Product
 Table 75. Samsung Biologics Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 76. Samsung Biologics Recent Development
 Table 77. FUJIFILM Diosynth Biotechnologies Company Details
 Table 78. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 79. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product
 Table 80. FUJIFILM Diosynth Biotechnologies Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 81. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 82. Charles River Laboratories Company Details
 Table 83. Charles River Laboratories Business Overview
 Table 84. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product
 Table 85. Charles River Laboratories Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 86. Charles River Laboratories Recent Development
 Table 87. Cytiva Company Details
 Table 88. Cytiva Business Overview
 Table 89. Cytiva Cell Gene Therapy Biomanufacturing Product
 Table 90. Cytiva Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 91. Cytiva Recent Development
 Table 92. Novasep Company Details
 Table 93. Novasep Business Overview
 Table 94. Novasep Cell Gene Therapy Biomanufacturing Product
 Table 95. Novasep Revenue in Cell Gene Therapy Biomanufacturing Business (US$ Million), 2021–2026
 Table 96. Novasep Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Cell Gene Therapy Biomanufacturing Picture
 Figure 2. Global Cell Gene Therapy Biomanufacturing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Cell Gene Therapy Biomanufacturing Market Share by Type: 2025 vs 2032
 Figure 4. Consumables Features
 Figure 5. Equipment Features
 Figure 6. Software Solutions Features
 Figure 7. Global Cell Gene Therapy Biomanufacturing Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Cell Gene Therapy Biomanufacturing Market Share by Application: 2025 vs 2032
 Figure 9. Life Science Companies Case Studies
 Figure 10. Contract Research Organizations Case Studies
 Figure 11. Contract Manufacturing Organizations Case Studies
 Figure 12. Cell Banks Case Studies
 Figure 13. Cell Gene Therapy Biomanufacturing Report Years Considered
 Figure 14. Global Cell Gene Therapy Biomanufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Cell Gene Therapy Biomanufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Cell Gene Therapy Biomanufacturing Market Share by Region: 2025 vs 2032
 Figure 17. Global Cell Gene Therapy Biomanufacturing Market Share by Players in 2025
 Figure 18. Global Cell Gene Therapy Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Cell Gene Therapy Biomanufacturing Revenue in 2025
 Figure 20. North America Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 22. United States Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 26. Germany Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Cell Gene Therapy Biomanufacturing Market Share by Region (2021–2032)
 Figure 34. China Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 42. Mexico Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Share by Country (2021–2032)
 Figure 46. Israel Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Cell Gene Therapy Biomanufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Lonza Group Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 51. Merck KGaA Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 52. WuXi AppTec Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 53. Catalent, Inc. Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 54. Samsung Biologics Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 55. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 56. Charles River Laboratories Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 57. Cytiva Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 58. Novasep Revenue Growth Rate in Cell Gene Therapy Biomanufacturing Business (2021–2026)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture